Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126777212 | 12677721 | 2 | F | 2015 | 20160829 | 20160823 | 20160902 | EXP | PHHY2016BR109550 | NOVARTIS | 0.00 | F | Y | 63.00000 | KG | 20160902 | CN | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126777212 | 12677721 | 1 | PS | EXELON PATCH | RIVASTIGMINE | 1 | Transdermal | PATCH (5 CM2), QD | Y | U | 22083 | 4.6 | MG | TRANS-THERAPEUTIC-SYSTEM | QD | ||||
| 126777212 | 12677721 | 2 | SS | EXELON PATCH | RIVASTIGMINE | 1 | Transdermal | PATCH (10 CM2), QD | Y | U | 22083 | 9.5 | MG | TRANS-THERAPEUTIC-SYSTEM | QD | ||||
| 126777212 | 12677721 | 3 | SS | EXELON PATCH | RIVASTIGMINE | 1 | Transdermal | PATCH 15 (CM2), QD | Y | U | 22083 | 13.3 | MG | TRANS-THERAPEUTIC-SYSTEM | QD | ||||
| 126777212 | 12677721 | 4 | C | LOSARTAN. | LOSARTAN | 1 | Oral | 50 MG, QD (STARTED USING 10 YEARS) | 0 | 50 | MG | TABLET | QD | ||||||
| 126777212 | 12677721 | 5 | C | LASIX | FUROSEMIDE | 1 | Oral | 40 MG, QD (STARTED USING 8 YEARS AGO) | 0 | 40 | MG | TABLET | QD | ||||||
| 126777212 | 12677721 | 6 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 20 MG, QD (STARTED USING 8 YEARS AGO) | 0 | 20 | MG | TABLET | QD | ||||||
| 126777212 | 12677721 | 7 | C | NEBILET | NEBIVOLOL | 1 | Oral | 5 MG, BID (STARTED USING 8 YEARS AGO) | 0 | 5 | MG | TABLET | BID | ||||||
| 126777212 | 12677721 | 8 | C | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | Oral | 25 MG, QD (STARTED USING 8 YEARS AGO) | 0 | 25 | MG | TABLET | QD | ||||||
| 126777212 | 12677721 | 9 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | 20 MG, QD (STARTED USING 8 YEARS AGO) | 0 | 20 | MG | TABLET | QD | ||||||
| 126777212 | 12677721 | 10 | C | ACETYLSALICYLIC ACID | ASPIRIN | 1 | Oral | 1 DF, QD (STARTED USING 8 YEARS AGO) | 0 | 1 | DF | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126777212 | 12677721 | 1 | Dementia Alzheimer's type |
| 126777212 | 12677721 | 4 | Mitral valve incompetence |
| 126777212 | 12677721 | 5 | Mitral valve incompetence |
| 126777212 | 12677721 | 6 | Prophylaxis |
| 126777212 | 12677721 | 7 | Mitral valve incompetence |
| 126777212 | 12677721 | 8 | Mitral valve incompetence |
| 126777212 | 12677721 | 9 | Prophylaxis |
| 126777212 | 12677721 | 10 | Prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126777212 | 12677721 | OT |
| 126777212 | 12677721 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126777212 | 12677721 | Asthenia | |
| 126777212 | 12677721 | Concomitant disease aggravated | |
| 126777212 | 12677721 | Dehydration | |
| 126777212 | 12677721 | Diarrhoea | |
| 126777212 | 12677721 | Disorientation | |
| 126777212 | 12677721 | Drug intolerance | |
| 126777212 | 12677721 | Hypotonia | |
| 126777212 | 12677721 | Malaise | |
| 126777212 | 12677721 | Memory impairment | |
| 126777212 | 12677721 | Muscle atrophy | |
| 126777212 | 12677721 | Syncope | |
| 126777212 | 12677721 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126777212 | 12677721 | 1 | 201506 | 0 | ||
| 126777212 | 12677721 | 2 | 201509 | 0 | ||
| 126777212 | 12677721 | 3 | 201511 | 201512 | 0 |